Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5576
Fortress Biotech
FBIO
$92.7M
| $90K | ﹤0.01% |
865
-680
| -44% | -$83.4K |
|
5577
Golub Capital BDC
GBDC
$3.34B
| $90K | ﹤0.01% |
5,439
+4,965
| +1,047% | +$85.6K |
|
5578
PUT
IDT Corp
IDT
$1.64B
| $90K | ﹤0.01% |
7,505
-4,556
| -38% | -$55.3K |
|
5579
CALL
Vail Resorts
MTN
$5.39B
| $90K | ﹤0.01% |
1,300
+700
| +117% | +$47.3K |
|
5580
PUT
Webster Financial
WBS
$12.8B
| $90K | ﹤0.01% |
3,600
-10,600
| -75% | -$282K |
|
|
MODN
5581
DELISTED
MODEL N, INC.
MODN
| $90K | ﹤0.01% |
9,981
+8,876
| +803% | +$159K |
|
|
BGG
5582
PUT
DELISTED
Briggs & Stratton Corp.
BGG
| $90K | ﹤0.01% |
4,500
-4,900
| -52% | -$98.8K |
|
|
BRY
5583
CALL
DELISTED
BERRY PETROLEUM CO CL A
BRY
| $90K | ﹤0.01% |
2,100
-900
| -30% | -$37.5K |
|
|
DST
5584
CALL
DELISTED
DST Systems Inc.
DST
| $90K | ﹤0.01% |
2,400
-7,000
| -74% | -$253K |
|
5585
Kratos Defense & Security Solutions
KTOS
$10.4B
| $89K | ﹤0.01% |
11,131
+10,550
| +1,816% | +$79.7K |
|
5586
Louisiana-Pacific
LPX
$5.4B
| $89K | ﹤0.01% |
5,260
-52,572
| -91% | -$869K |
|
5587
MaxLinear
MXL
$6.12B
| $89K | ﹤0.01% |
11,141
+2,312
| +26% | +$18K |
|
5588
PUT
Insperity
NSP
$1.95B
| $89K | ﹤0.01% |
4,800
| – | – |
|
|
FCRD
5589
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $89K | ﹤0.01% |
5,953
+2,014
| +51% | +$31.3K |
|
5590
CALL
Brown-Forman Class B
BF.B
$13B
| $88K | ﹤0.01% |
4,063
-4,375
| -52% | -$98.6K |
|
|
5591
PUT
Brown-Forman Class B
BF.B
$13B
| $88K | ﹤0.01% |
4,063
-4,687
| -54% | -$106K |
|
5592
CALL
Century Aluminum
CENX
$4.64B
| $88K | ﹤0.01% |
11,000
-8,500
| -44% | -$75.2K |
|
5593
PUT
Exelixis
EXEL
$14.3B
| $88K | ﹤0.01% |
17,500
+7,700
| +79% | +$39.9K |
|
5594
Lisata Therapeutics
LSTA
$10.2M
| $88K | ﹤0.01% |
+73
| New | +$81.1K |
|
5595
Invesco Global Clean Energy ETF
PBD
$190M
| $88K | ﹤0.01% |
8,000
| – | – |
|
5596
CALL
W.R. Berkley
WRB
$26.8B
| $88K | ﹤0.01% |
7,088
+3,713
| +110% | +$46.6K |
|
|
SPPI
5597
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $88K | ﹤0.01% |
11,000
-16,900
| -61% | -$137K |
|
|
OMN
5598
DELISTED
OMNOVA Solutions Inc.
OMN
| $88K | ﹤0.01% |
11,047
+5,474
| +98% | +$44.7K |
|
|
GST
5599
DELISTED
Gastar Exploration Inc.
GST
| $88K | ﹤0.01% |
29,551
-35,004
| -54% | -$121K |
|
|
REE
5600
DELISTED
RARE ELEMENT RES LTD
REE
| $88K | ﹤0.01% |
44,132
+9,108
| +26% | +$20.2K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.